Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Phase I Genitourinary Oncology

Udai Bhatt

MD

🏢University of Texas MD Anderson Cancer Center🌐USA

Associate Professor

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Udai Bhatt at MD Anderson contributes to early clinical development of novel agents in genitourinary cancers, including prostate cancer and renal cell carcinoma. His work on phase I GU trials integrating pharmacodynamic biomarkers with clinical endpoints and on early-phase combination regimens reflects the modern phase I approach of embedding translational science into first-in-human studies.

Share:

🧪Research Fields 研究领域

GU phase I trials
prostate cancer early phase
RCC early phase
phase I biomarker integration
novel GU oncology agents

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Udai Bhatt 的研究动态

Follow Udai Bhatt's research updates

留下邮箱,当我们发布与 Udai Bhatt(University of Texas MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment